The nature and origin of the B-chronic lymphocytic leukemia cell: a tentative model

被引:14
作者
Caligaris-Cappio, F
Ghia, P
机构
[1] Ist Sci San Raffaele, I-20132 Milan, Italy
[2] Univ Vita Salute San Raffaele, Dept Oncol, I-20132 Milan, Italy
[3] Univ Turin, Sch Med, Dept Oncol Sci, I-10060 Candiolo, TO, Italy
[4] IRCC, Lab Canc Immunol, I-10060 Candiolo, Italy
关键词
D O I
10.1016/j.hoc.2004.04.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chronic lymphocytic leukemia cells have the profile of antigen (Ag) activated memory B cells but also show a constellation of T-cell-associated properties. We suggest that the early transforming events may occur in an early lymphoid progenitor. This precursor differentiates into a mature B cell that, though retaining T-cell features, has a functional B-cell receptor that may allow Ag intervention to trigger clonal expansion. This model has to cope with the existence of at least two subsets of the disease as defined by their IgV(H) genes mutational status. Mutated cases have a lower capacity to interact with Ag and are reminiscent of anergic cells. This explains their less harmful behavior as compared with unmutated case, which have a more aggressive potential likely because they had the opportunity to acquire additional chromosomal aberrations after repeated rounds of Ag stimulation and replication.
引用
收藏
页码:849 / +
页数:16
相关论文
共 79 条
[31]  
Harris N L, 2001, Hematology Am Soc Hematol Educ Program, P194, DOI 10.1182/asheducation-2001.1.194
[32]   B-1 cells: the lineage question revisited [J].
Herzenberg, LA .
IMMUNOLOGICAL REVIEWS, 2000, 175 :9-22
[33]   Notch2 is involved in the overexpression of CD23 in B-cell chronic lymphocytic leukemia [J].
Hubmann, R ;
Schwarzmeier, JD ;
Shehata, M ;
Hilgarth, M ;
Duechler, M ;
Dettke, M ;
Berger, R .
BLOOD, 2002, 99 (10) :3742-3747
[34]   Clinical characteristics of familial B-CLL in the National Cancer Institute Familial Registry [J].
Ishibe, N ;
Sgambati, MT ;
Fontaine, L ;
Goldin, LR ;
Jain, N ;
Weissman, N ;
Marti, GE ;
Caporso, NE .
LEUKEMIA & LYMPHOMA, 2001, 42 (1-2) :99-108
[35]  
Juliusson G, 1997, HEMATOL CELL THER, V39, pS41, DOI 10.1007/s00282-997-0041-4
[36]  
Kaleem Z, 2001, AM J CLIN PATHOL, V115, P396
[37]   THE DEVELOPMENT AND REPERTOIRE OF B-1 CELLS (CD5 B-CELLS) [J].
KANTOR, AB .
IMMUNOLOGY TODAY, 1991, 12 (11) :389-391
[38]   CD2 is expressed by a subpopulation of normal B cells and is frequently present in mature B-Cell neoplasms [J].
Kingma, DW ;
Imus, P ;
Xie, XY ;
Jasper, G ;
Sorbara, L ;
Stewart, C ;
Stetler-Stevenson, M .
CYTOMETRY, 2002, 50 (05) :243-248
[39]  
KIPPS TJ, 1993, BLOOD, V81, P2475
[40]   Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukaemia [J].
Kitada, S ;
Zapata, JM ;
Andreeff, M ;
Reed, JC .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 106 (04) :995-1004